Trelagliptin Succinate | Interleukin Related interleukin-related.com

Product Name :
Trelagliptin Succinate

Search keywords :
Trelagliptin

drugId :
null

Target Vo:
Dipeptidyl peptidase IV

Target Vo Short Name :
DPP4

Moa_Name:
Dipeptidyl peptidase IV inhibitors

First Approval Country :
Japan

First Approval Date Filter:
2015

Origin Company_Name :
Takeda Pharmaceutical Co Ltd

Active Company_Name :
Sichuan Kelun Pharmaceutical Co Ltd

Active Indication_Name:
Diabetes Mellitus, Type 2

In Active Indication_Name:
Diabetes Mellitus

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Cathepsin B Antibody
Glutathione Synthetase Antibody
ACE Antibody: ACE Antibody is an unconjugated, approximately 147 kDa, rabbit-derived, anti-ACE polyclonal antibody. ACE Antibody can be used for: WB, ELISA, IHC-P, IHC-F, ICC, IF expriments in human, mouse, rat, and predicted: dog, pig, cow, sheep background without labeling.

Author: Interleukin Related

Related Posts